Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Top-Line Phase III Results From GALA Study

Go back to Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Top-Line Phase III Results From GALA Study